AstraZeneca Outlines Branded Generics Strategy at Emerging Markets Event
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca plans to broaden its presence across a wide range of developing markets, including small and mid-sized ones, not only to maximize growth but also to smooth out variations in growth rates across countries and regions, top company executives said in a detailed presentation to analysts on March 16